CHAMBERS MICHAEL ANDREW purchased 4.2% of their position (9.98K shares) of SAREPTA THERAPEUTICS, INC. on the open market
Open‑market purchase worth $1.09M — a small addition. The strongest form of insider conviction signal.
P · 2 purchases
Filed: 8/15/2023ACC: 0001209191-23-045766
Director
Since Jun 2022
+9.98K
Net shares
Net buyer
$1.09M
Total acquired
2
Open market trades
2B · 0S
2
Total transactions
9.98K acquired
Non-Derivative Transactions2
Common Stock
Indirect
Shares
+5.95K
Price / share
$109.19
Trade value
$649.35K
% of position
2.5%
8/14/2023
237.02K→242.96K
Common Stock
Indirect
Shares
+4.03K
Price / share
$109.89
Trade value
$443.08K
% of position
1.7%
8/14/2023
242.96K→247K
Total
Net shares
+9.98K
Net value
$1.09M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Indirect | 8/14/2023 | P · Purchase | +5.95K | $109.19 | $649.35K | 2.5% | 237.02K | 242.96K |
| Common Stock Indirect | 8/14/2023 | P · Purchase | +4.03K | $109.89 | $443.08K | 1.7% | 242.96K | 247K |
| Total | +9.98K | $1.09M | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)1
Common Stock
DirectShares owned6.43K
Total
6.43K direct6.43K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 6.43K | Direct |
| Total | 6.43K | 6.43K direct |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported